机译:与FGFR3表达,配体激活和药物抑制相关的多发性骨髓瘤磷酸酪氨酸蛋白组学
Molecular Structure and Function Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8 Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5S 1A8;
Molecular Structure and Function Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8 Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5S 1A8;
Molecular Structure and Function Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8 Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5S 1A8;
Molecular Structure and Function Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8 Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5S 1A8;
Molecular Structure and Function Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8 McLaughlin Centre for Molecular Medicine, University of Toronto, Toronto, ON, Canada M5G 1L7;
lnfochromics Inc., Toronto, ON, Canada M5G 1L7;
lnfochromics Inc., Toronto, ON, Canada M5G 1L7 Center for Proteomics and Bioinformatics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106;
lnfochromics Inc., Toronto, ON, Canada M5G 1L7;
McLaughlin Centre for Molecular Medicine, University of Toronto, Toronto, ON, Canada M5G 1L7 Hematology-Oncology, Princess Margaret Hospital, Toronto, ON, Canada M5G 1X8;
McLaughlin Centre for Molecular Medicine, University of Toronto, Toronto, ON, Canada M5G 1L7 Hematology-Oncology, Princess Margaret Hospital, Toronto, ON, Canada M5G 1X8;
Molecular Structure and Function Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8 Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5S 1A8 McLaughlin Centre for Molecular Medicine, University of Toronto, Toronto, ON, Canada M5G 1L7 Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, Canada M5G 1L7;
proteomics; syndecan; mass spectrometry; comodulation;
机译:FGFR3在多发性骨髓瘤中异位表达的谜团:关键的起始事件或仅仅是肿瘤进展过程中突变激活的靶标。
机译:低Beclin-1表达预测多发性骨髓瘤用免疫调节药物治疗的患者的总生存期提高,并将自噬抑制确定为有希望的潜在可药物治疗的新治疗靶标:奥地利骨髓瘤注册机构(AMR)的分析
机译:Toll样受体在多发性骨髓瘤患者中的表达和功能:toll样受体配体通过激活核因子-κB促进多发性骨髓瘤细胞的生长和存活。
机译:国际蛋白质索引到Affymetrix探针组标识符的映射,用于关联多发性骨髓瘤的基因组学和蛋白质组学表达谱
机译:150名新诊断的多发性骨髓瘤患者的成纤维细胞生长因子受体3(FGFR3)的突变,SNP和同工型分析。
机译:与FGFR3表达配体激活和药物抑制相关的多发性骨髓瘤磷酸酪氨酸蛋白组学
机译:与FGFR3表达,配体激活和药物抑制相关的多发性骨髓瘤磷酸酪氨酸蛋白组学
机译:通过抑制多发性骨髓瘤中的一般转录调节因子来了解c-myc表达的选择性下调。